Study of Irinotecan and Bortezomib in Children With Recurrent/Refractory Neuroblastoma

NCT00644696 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Neuroblastoma

Interventions

DRUG: Irinotecan and Bortezomib

Sponsor

University of Michigan Rogel Cancer Center

Collaborators

[object Object]